Lunai Bioworks Inc. Common Stock (LNAI)
Stock · NASDAQ · Health Care
$2.37as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Resistance level
$2.93
Industry
Biotechnology: Pharmaceutical Preparations
About LNAI
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 29
- Website
- www.lunaibioworks.com
Fundamentals
- 1-day range
- $2.15$2.25
- Market cap
- $10.84M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-61.52
- Dividend yield
- —
- Beta
- 0.32
- Avg. volume
- 1.00M
52-week range
$1.21$21.2
Next earnings: September 28, 2026
Lunai Bioworks Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- LNAILunai Bioworks Inc. Common Stock$2.37▲ 0.85%Market cap $10.84MP/E —$1.21$21.2
- PHIOPhio Pharmaceuticals Corp. Common Stock$1.13▲ 0.45%Market cap $11.97MP/E —$0.8127$4.19
- GDTCCytoMed Therapeutics Limited Ordinary Shares$0.92▼ 4.17%Market cap $9.50MP/E —$0.6801$3.68
- AKTXAkari Therapeutics plc ADS$11.03▲ 22.42%Market cap $12.88MP/E Infinity$3.02$49.6
- COCPCocrystal Pharma Inc. Common Stock$1.11▼ 2.63%Market cap $12.96MP/E —$0.76$2.67
- CNSPCNS Pharmaceuticals Inc. Common Stock$5.52▲ 0.11%Market cap $8.46MP/E —$1.9$10.59
- SNGXSoligenix Inc. Common Stock$0.38▲ 0.00%Market cap $8.22MP/E —$0.28$3.22
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| LNAI Lunai Bioworks Inc. Common Stock | $10.84M | — | $2.37 | ▲ 0.85% | $1.21$21.2 |
| PHIO Phio Pharmaceuticals Corp. Common Stock | $11.97M | — | $1.13 | ▲ 0.45% | $0.8127$4.19 |
| GDTC CytoMed Therapeutics Limited Ordinary Shares | $9.50M | — | $0.92 | ▼ 4.17% | $0.6801$3.68 |
| AKTX Akari Therapeutics plc ADS | $12.88M | Infinity | $11.03 | ▲ 22.42% | $3.02$49.6 |
| COCP Cocrystal Pharma Inc. Common Stock | $12.96M | — | $1.11 | ▼ 2.63% | $0.76$2.67 |
| CNSP CNS Pharmaceuticals Inc. Common Stock | $8.46M | — | $5.52 | ▲ 0.11% | $1.9$10.59 |
| SNGX Soligenix Inc. Common Stock | $8.22M | — | $0.38 | ▲ 0.00% | $0.28$3.22 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.